https://charts.traderzeitung.de/phases/US05348Y1055
string(1369) "{"isin":"US05348Y1055","name":"Avalyn Pharma Inc","stock_id":130665958,"generated_at":"2026-10-11 02:25:00","days":[{"date":"2026-10-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":25.59,"close_at":"2026-10-07 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-08","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":25.74,"close_at":"2026-10-08 21:59:00","complete":true,"perf_pct":0.5862},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-09","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":25.76,"close_at":"2026-10-09 21:59:00","complete":true,"perf_pct":0.0777},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Avalyn Pharma Aktie News & Nachrichten
Trading-Room

Avalyn Pharma Aktie News & Nachrichten

[WKN: A42B38 | Symbol: AVLN]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Avalyn Pharma

Avalyn Pharma: Morgan Stanley sieht 84 % Kurspotenzial - Studienergebnisse im 2. Halbjahr 2027 könnten verbleibenden Risiken einer potenziellen Multi-Blockbuster-Chance deutlich minimieren

Frischer Wind durch erfolgreichen Börsengang und Pipeline-Fortschritte Der Börsengang von Avalyn...

TOP-5-Kursziele der Analysten am 26.05.26

Lumexa Imaging Holdings Inc. [US55024U1097]: JP Morgan hat die Einschätzung auf "Buy" mit Ziel bei...

  • ‹
  • 1
  • ›
Avalyn Pharma Nachrichtenticker öffnen
MT Newswires 02.10.2026 13:19 Uhr

Raymond James nimmt Avalyn Pharma mit Rating Outperform und Kursziel von 60 USD auf

07:18 AM EDT, 10/02/2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid

MT Newswires 12.08.2026 14:38 Uhr

Nettoverlust von Avalyn Pharma im Q2 ausgeweitet

08:30 AM EDT, 12.08.2026 (MT Newswires) -- Avalyn Pharma (AVLN) meldete am Mittwoch einen Nettoverlust im Q2 von 28,9 Millionen US-Dollar, womit sich

MT Newswires 12.08.2026 14:13 Uhr

Earnings Flash (AVLN): Avalyn Pharma meldet Nettoverlust im Q2 von 28,9 Mio. $, ggü. FactSet-Schätzung von 28,6 Mio. $ Verlust

08:12 AM EDT, 12.08.2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid